Gilead Rode An Unexpected Source For Its Sales Beat, But Profit Came Up ShortInvestors Business Daily • 02/06/24
Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2024 DividendBusiness Wire • 02/06/24
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial ResultsBusiness Wire • 02/06/24
Exploring Analyst Estimates for Gilead (GILD) Q4 Earnings, Beyond Revenue and EPSZacks Investment Research • 02/01/24
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell TherapyBusiness Wire • 01/30/24
Gilead Sciences to Release Fourth Quarter & Full Year 2023 Financial Results on Tuesday, February 6, 2024Business Wire • 01/23/24
Gilead Sciences Stock Crashes 9% After Cancer Drug Fails A Key TestInvestors Business Daily • 01/22/24